Stefanie Possekel has spent more than 20 years in the pharmaceutical and biotech industry and technology transfer and has broad experience in in- and out licensing of clinical and preclinical projects. In particular, she successfully worked on a number of major research and development collaborations with academic institutions.
She joined…
Stefanie Possekel has spent more than 20 years in the pharmaceutical and biotech industry and technology transfer and has broad experience in in- and out licensing of clinical and preclinical projects. In particular, she successfully worked on a number of major research and development collaborations with academic institutions.
She joined…
Before becoming General Manager of Ascenion, Christian Stein headed the project management department at the Fraunhofer Patent Centre for German Research for four years.
From 2020 to 2022 he was Chairman of the Board of TransferAllianz, the German Knowledge and Technology Transfer Association, representing the TTOs of around 100 scientific…
Before becoming General Manager of Ascenion, Christian Stein headed the project management department at the Fraunhofer Patent Centre for German Research for four years.
From 2020 to 2022 he was Chairman of the Board of TransferAllianz, the German Knowledge and Technology Transfer Association, representing the TTOs of around 100 scientific…
Phase I study initiated with candidate against multidrug-resistant germs
6 June 2018, Munich – The Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knoell-Institute (HKI) together with the Ludwig-Maximilians-Universität München (LMU) have brought a novel compound discovered at the HKI all the way from basic…
The U.S. Food and Drug Administration (FDA) has extended the scope of Shire’s VONVENDI to include perioperative management of bleeding in adults with von Willebrand disease (VWD). The therapy was first approved in the US in December 2015 for on-demand treatment and control of bleeding episodes. It is the first and only recombinant treatment for…
In April, the members of the rapidly growing TechnologieAllianz e.V. teamed up with founders, investors, scientists and politicians for the 3rd TechnologieAllianz Annual Conference. This year’s exchange focused on the question of how tech and life science startups can better succeed. A total of 200 participants shared their experiences and…
This year’s BioVaria was the event in 2018 for early-stage, life-science European startups to connect with investors, with a record number of company founders and investors participating in the revamped and expanded Startup Pitch and Partner program.
15 startups from across Europe attended BioVaria, 10 of which were pre-selected by a jury of…
Startup Awards go to OPSYON and LIfT Biosciences
26 April 2018, Munich, Germany – Over 250 innovative minds gathered in Munich on April 23-24 for the 11th BioVaria to discuss emerging life-science trends and initiate partnerships between academia and industry. 63 peer-selected, patent-protected technologies originating from as many research…
Berlin Cures, one of Ascenion’s portfolio companies, has announced positive Phase I results for its lead candidate BC007 for the treatment of heart failure. 68 subjects were evaluated in the clinical study. The candidate was very well tolerated and a single dose was able to completely and sustainably eliminate autoantibodies targeting the beta-1…
BioVaria brings together Europe’s top scientists and technology transfer professionals with potential licensees and investors from the international biopharmaceutical industry. Top-tier academic institutions and universities from all over Europe will present over 60 attractive partnering and investment opportunities in the life-science field.
…
Join over 400 experts in medical innovation to discuss global challenges and pioneering technologies in healthcare. During two conference days, you will get access to entrepreneurs, scientists and clinicians, policymakers, investors, and industry leaders.
Our agenda features inspiring keynote speakers from Germany, Europe, Israel, Canada, the…
Technology sneak peek from Ascenion: Five breakthrough life-science inventions
9 March 2018, Munich, Germany – On 23–24 April 2018, decision makers from biotech, pharma and finance will meet in Munich for the 11th BioVaria to learn about emerging life-science trends and initiate partnerships with academic inventors, entrepreneurs and technology…
